Madrigal Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:MDGL) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 1.04 B996.63 M1.02 B1.36 B1.26 B Total liabilities 287.86 M285.99 M319.4 M736.73 M656.9 M Total equity 754.38 M710.64 M695.98 M625.73 M602.69 M Total liabilities & shareholders' equities 1.04 B996.63 M1.02 B1.36 B1.26 B Total debt 117.57 M118 M118.38 M339.75 M339.88 M Net debt -813.68 M-730.06 M-683.65 M-775 M-643.68 M

뉴스

United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

ALT Pemvidutide Explained: What Makes It Different in MASH

Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Madrigal Pharmaceuticals 임원 Dier, 85.4만 달러 상당 주식 매도

Madrigal Pharmaceuticals EVP Dier sells $854k in stock

마드리갈 제약 CEO 시볼드, 71만 8천 달러 상당 주식 매각

Madrigal Pharmaceuticals CEO Sibold sells $718k in shares

Madrigal Pharmaceuticals 임원, 15만 5천 달러 상당 주식 매도